Cigarette smoking in the HIV-infected population

Proc Am Thorac Soc. 2011 Jun;8(3):313-9. doi: 10.1513/pats.201009-058WR.

Abstract

As mortality due to AIDS-related causes has decreased with the use of antiretroviral therapy, there has been a rise in deaths related to non-AIDS-defining illnesses. Given the exceedingly high prevalence of cigarette smoking among individuals living with HIV infection, tobacco has been implicated as a major contributor to this paradigm shift. Evidence suggests that smoking-related illnesses, such as cardiovascular disease, respiratory illnesses, and certain malignancies, contribute substantially to morbidity and mortality among HIV-infected persons. In this review, we summarize the adverse health consequences of smoking relevant to HIV-infected individuals and discuss smoking cessation in this unique population, including a discussion of barriers to quitting and a review of studies that have examined smoking cessation interventions.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Retroviral Agents / therapeutic use
  • Body Mass Index
  • Cardiovascular Diseases / epidemiology
  • Drug Interactions
  • Educational Status
  • HIV Infections / epidemiology*
  • Humans
  • Mental Disorders / epidemiology
  • Neoplasms / epidemiology
  • Nicotinic Agonists / therapeutic use
  • Pneumonia, Bacterial / epidemiology
  • Pulmonary Disease, Chronic Obstructive / epidemiology
  • Quality of Life
  • Risk Factors
  • Smoking / adverse effects*
  • Smoking / epidemiology
  • Smoking Cessation*
  • Social Class
  • Social Support
  • Substance-Related Disorders / epidemiology

Substances

  • Anti-Retroviral Agents
  • Nicotinic Agonists